A Brief History and Advancement of Contraceptive Multipurpose Prevention Technology (cMPT) Products

References

• The Initiative for Multipurpose Prevention Technologies. IMPT for reproductive health. Available from: https://theimpt.org/. Accessed December 19, 2022.
   Google Scholar
• United Nations. “Staggering number” of unintended pregnancies reveals failure to uphold women’s rights. UN News; 2022. Available from: https://news.un.org/en/story/2022/03/1115062. Accessed February 18, 2023.
   Google Scholar
• World Health Organization. Sexually transmitted infections (STIs). Available from: https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis). Accessed February 27, 2023.
   Google Scholar
• Morrow KM, Fava JL, Rosen RK, et al. Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties. J Acquir Immune Defic Syndr. 2007;45(1):93–101. doi:10.1097/QAI.0b013e3180415ded
   PubMed Web of Science ®Google Scholar
• Gruber F, Lipozenčić J, Kehler T. History of venereal diseases from antiquity to the renaissance. Acta Dermatovenerol Croat ADC. 2015;23(1):1–11.
   PubMed Web of Science ®Google Scholar
• Burg G. History of sexually transmitted infections (STI). G Ital Dermatol E Venereol Organo Uff Soc Ital Dermatol E Sifilogr. 2012;147(4):329–340.
   PubMed Web of Science ®Google Scholar
• Khan F, Mukhtar S, Dickinson IK, Sriprasad S. The story of the condom. Indian J Urol IJU J Urol Soc India. 2013;29(1):12–15. doi:10.4103/0970-1591.109976
   PubMedGoogle Scholar
• Fallopio G. De Morbo Gallico Liber (The French Disease) Describing the Earliest Documented Use of Condoms; 1564. Available from: https://books.google.com/books?id=lQk8AAAAcAAJ&printsec=frontcover&source=gbs_ge_summary_r&cad=0#v=onepage&q&f=false. Accessed February 18, 2023.
   Google Scholar
• Wertheim JO, Smith MD, Smith DM, Scheffler K, Kosakovsky Pond SL. Evolutionary origins of human herpes simplex viruses 1 and 2. Mol Biol Evol. 2014;31(9):2356–2364. doi:10.1093/molbev/msu185
   PubMed Web of Science ®Google Scholar
• Briggs P, Kovacs G, Guillebaud J. Contraception: A Casebook from Menarche to Menopause. Cambridge University Press; 2013.
   Google Scholar
• Conrad LI, Neve M, Nutton V, Porter R, Wear A. The Western Medical Tradition: 800 BC to AD 1800. Cambridge University Press; 1995.
   Google Scholar
• Rothschild BM. History of syphilis. Clin Infect Dis. 2005;40(10):1454–1463. doi:10.1086/429626
   PubMed Web of Science ®Google Scholar
• Heckel NJ. A Study of the Pathologic Alterations in the Female Bladder and Urethra Resulting from Infection with Trichomonas Vaginalis1. J Urol. 1936;35(5):520–523. doi:10.1016/S0022-5347(17)72217-3
   Google Scholar
• Tjia KF, van Putten JPM, Pels E, Zanen HC. The interaction between Neisseria gonorrhoeae and the human cornea in organ culture. Graefes Arch Clin Exp Ophthalmol. 1988;226(4):341–345. doi:10.1007/BF02172964
   PubMed Web of Science ®Google Scholar
• Beem MO, Saxon EM. Respiratory-tract colonization and a distinctive pneumonia syndrome in infants infected with chlamydia trachomatis. N Engl J Med. 1977;296(6):306–310. doi:10.1056/NEJM197702102960604
   PubMed Web of Science ®Google Scholar
• Alharbi SA, Wainwright M, Alahmadi TA, Salleeh HB, Faden AA, Chinnathambi A. What if Fleming had not discovered penicillin? Saudi J Biol Sci. 2014;21(4):289–293. doi:10.1016/j.sjbs.2013.12.007
   PubMed Web of Science ®Google Scholar
• Korber B, Muldoon M, Theiler J, et al. Timing the Ancestor of the HIV-1 Pandemic Strains. Science. 2000;288(5472):1789–1796. doi:10.1126/science.288.5472.1789
   PubMed Web of Science ®Google Scholar
• Watkins ES. How the Pill Became a Lifestyle Drug: the Pharmaceutical Industry and Birth Control in the United States Since 1960. Am J Public Health. 2012;102(8):1462–1472. doi:10.2105/AJPH.2012.300706
   PubMed Web of Science ®Google Scholar
• Roepke CL, Schaff EA. Long tail strings: impact of the dalkon shield 40 years later. Open J Obstet Gynecol. 2014;04(16):996. doi:10.4236/ojog.2014.416140
   Google Scholar
• Nakashima AK, Fleming PL. HIV/AIDS Surveillance in the United States, 1981-2001. J Acquir Immune Defic Syndr. 2003;32:S68.
   PubMed Web of Science ®Google Scholar
• Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnürch HG, Zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci. 1983;80(2):560–563. doi:10.1073/pnas.80.2.560
   PubMed Web of Science ®Google Scholar
• Kolata G. FDA Approves AZT. Science. 1987;235(4796):1570.
   PubMed Web of Science ®Google Scholar
• Peters A, Jansen W, van Driel F. The female condom: the international denial of a strong potential. Reprod Health Matters. 2010;18(35):119–128. doi:10.1016/S0968-8080(10)35499-1
   PubMed Web of Science ®Google Scholar
• Ray M, Logan R, Sterne JA; HIV-Causal Collaboration. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS Lond Engl. 2010;24(1):123–137. doi:10.1097/QAD.0b013e3283324283
   PubMed Web of Science ®Google Scholar
• Harrison PF. A new model for collaboration: the alliance for microbicide development. Int J Gynaecol Obstet. 1999;67(Suppl 2):S39–S53. doi:10.1016/s0020-7292(99)00145-9
   PubMedGoogle Scholar
• Food and Drug Administration. Approval Package for Mirena (levonorgestrel-releasing intrauterine system). FDA; 2015. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/021225orig1s031.pdf. Accessed February 19, 2023.
   Google Scholar
• McLemore MR. Gardasil: introducing the new human papillomavirus vaccine. Clin J Oncol Nurs. 2006;10(5):559–560. doi:10.1188/06.CJON.559-560
   PubMedGoogle Scholar
• Bowers R. FDA issues warning for nonoxynol-9 products. AIDS Alert. 2008;23(4):44–45.
   PubMedGoogle Scholar
• McKenna M The last drug that can fight gonorrhea is starting to falter. Wired. Available from: https://www.wired.com/story/the-last-drug-that-can-fight-gonorrhea-is-starting-to-falter/. Accessed February 27, 2023.
   Google Scholar
• Suthutvoravut S, Kamyarat O. Spermicidal effects of lemon juice and juices from other natural products. Agric Nat Resour. 2016;50(2):133–138. doi:10.1016/j.anres.2015.09.004
   Google Scholar
• Grant M, Hamer D, Hope T, et al. Whither or Wither Microbicides? Science. 2008;321(5888):532–534. doi:10.1126/science.1160355
   PubMed Web of Science ®Google Scholar
• Planned Parenthood. What Is the Effectiveness of Condoms? Available from: https://www.plannedparenthood.org/learn/birth-control/condom/how-effective-are-condoms. Accessed February 18, 2023.
   Google Scholar
• Marfatia YS, Pandya I, Mehta K. Condoms: past, present, and future. Indian J Sex Transm Dis AIDS. 2015;36(2):133–139. doi:10.4103/0253-7184.167135
   PubMedGoogle Scholar
• Smita J, Neelam J, Rochelle DY, et al. Comparative acceptability study of the Reality® female condom and the version 4 of modified Reddy female condom in India. Contraception. 2005;72(5):366–371. doi:10.1016/j.contraception.2005.05.014
   PubMed Web of Science ®Google Scholar
• Fasehun LK, Lewinger S, Fasehun O, Brooks M. Barriers and facilitators to acceptability of the female condom in low- and middle-income countries: a systematic review. Ann Glob Health. 2016;88(1):20. doi:10.5334/aogh.3612
   Google Scholar
• Omar RF, Trottier S, Brousseau G, Lamarre A, Gagnon Null A, Bergeron MG. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study. Contraception. 2008;77(6):447–455. doi:10.1016/j.contraception.2008.01.015
   PubMed Web of Science ®Google Scholar
• Mbopi-Keou FX, Trottier S, Omar RF, et al. A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women. Contraception. 2010;81(1):79–85. doi:10.1016/j.contraception.2009.07.002
   PubMed Web of Science ®Google Scholar
• Omar RF, Leboeuf M, Lemyre M, et al. A pre-phase iii efficacy trial of the spermicide/contraceptive effect of the invisible condom, a non-hormonal vaginal gel, in women from Canada. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. 2022;44(2):175–181. doi:10.1016/j.jogc.2021.09.018
   PubMed Web of Science ®Google Scholar
• Schimpf U, Caldas-Silveira E, Katchan L, et al. Topical reinforcement of the cervical mucus barrier to sperm. Sci Transl Med. 2022;14(673):eabm2417. doi:10.1126/scitranslmed.abm2417
   PubMed Web of Science ®Google Scholar
• Miller CJ, Alexander NJ, Sutjipto S, et al. Effect of virus dose and nonoxynol-9 on the genital transmission of siv in rhesus macaques. J Med Primatol. 1990;19(3–4):401–409. doi:10.1111/j.1600-0684.1990.tb00445.x
   PubMed Web of Science ®Google Scholar
• Stephenson J. Widely used spermicide may increase, not decrease, risk of HIV transmission. JAMA. 2000;284(8):949. doi:10.1001/jama.284.8.949
   PubMed Web of Science ®Google Scholar
• Burke AE, Barnhart K, Jensen JT, et al. Contraceptive Efficacy, Acceptability, and Safety of C31G and Nonoxynol-9 Spermicidal Gels: a Randomized Controlled Trial. Obstet Gynecol. 2010;116(6):1265. doi:10.1097/AOG.0b013e3181fc3b1a
   PubMed Web of Science ®Google Scholar
• Feldblum PJ, Adeiga A, Bakare R, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One. 2008;3(1):e1474. doi:10.1371/journal.pone.0001474
   PubMed Web of Science ®Google Scholar
• Bhosale VV, Asthana OP, Gaur SPS. Efficacy and safety of herbal spermicidal contraceptive, Consap. Curr Sci. 2013;104(12):1701–1703.
   Web of Science ®Google Scholar
• Rajasekaran M, Nair AGR, Hellstrom WJG, Sikka SC. Spermicidal activity of an antifungal saponin obtained from the tropical herb Mollugo pentaphylla. Contraception. 1993;47(4):401–412. doi:10.1016/0010-7824(93)90037-8
   PubMed Web of Science ®Google Scholar
• Pirrone V, Wigdahl B, Krebs FC. The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1. Antiviral Res. 2011;90(3):168–182. doi:10.1016/j.antiviral.2011.03.176
   PubMed Web of Science ®Google Scholar
• Patel S, Hazrati E, Cheshenko N, et al. Seminal plasma reduces the effectiveness of topical polyanionic microbicides. J Infect Dis. 2007;196(9):1394–1402. doi:10.1086/522606
   PubMed Web of Science ®Google Scholar
• Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet Lond Engl. 2008;372(9654):1977–1987. doi:10.1016/S0140-6736(08)61842-5
   PubMed Web of Science ®Google Scholar
• Tan S, Lu L, Li L, et al. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection. PLoS One. 2013;8(3):e59777. doi:10.1371/journal.pone.0059777
   PubMed Web of Science ®Google Scholar
• Weitzel M, North BB, Waller D. Development of multipurpose technologies products for pregnancy and STI prevention: update on polyphenylene carboxymethylene MPT gel development†. Biol Reprod. 2020;103(2):299–309. doi:10.1093/biolre/ioaa087
   PubMed Web of Science ®Google Scholar
• Price CF, Tyssen D, Sonza S, et al. SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans. PLoS One. 2011;6(9):e24095. doi:10.1371/journal.pone.0024095
   PubMed Web of Science ®Google Scholar
• Moscicki AB, Kaul R, Ma Y, et al. Measurement of mucosal biomarkers in a Phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety. J Acquir Immune Defic Syndr. 2012;59(2):134–140. doi:10.1097/QAI.0b013e31823f2aeb
   PubMed Web of Science ®Google Scholar
• McGowan I, Gomez K, Bruder K, et al. Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004). AIDS Lond Engl. 2011;25(8):1057–1064. doi:10.1097/QAD.0b013e328346bd3e
   PubMed Web of Science ®Google Scholar
• Fernandes T, Baxi K, Sawarkar S, Sarmento B, Das Neves J. Vaginal multipurpose prevention technologies: promising approaches for enhancing women’s sexual and reproductive health. Expert Opin Drug Deliv. 2020;17(3):379–393. doi:10.1080/17425247.2020.1728251
   PubMed Web of Science ®Google Scholar
• Caminade AM. Dendrimers, an emerging opportunity in personalized medicine? J Pers Med. 2022;12(8):1334. doi:10.3390/jpm12081334
   PubMed Web of Science ®Google Scholar
• Mirmonsef P, Gilbert D, Zariffard MR, et al. The effects of commensal bacteria on innate immune responses in the female genital tract. Am J Reprod Immunol. 2011;65(3):190–195. doi:10.1111/j.1600-0897.2010.00943.x
   PubMed Web of Science ®Google Scholar
• Mayer KH, Peipert J, Fleming T, et al. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clin Infect Dis off Publ Infect Dis Soc Am. 2001;32(3):476–482. doi:10.1086/318496
   PubMed Web of Science ®Google Scholar
• Bouvet JP, Grésenguet G, Bélec L. Vaginal pH neutralization by semen as a cofactor of HIV transmission. Clin Microbiol Infect. 1997;3(1):19–23. doi:10.1111/j.1469-0691.1997.tb00246.x
   PubMedGoogle Scholar
• Zeitlin L, Hoen TE, Achilles SL, et al. Tests of buffergel for contraception and prevention of sexually transmitted diseases in animal models. Sex Transm Dis. 2001;28(7):417.
   PubMed Web of Science ®Google Scholar
• Su S, Vincent KL. Lactic acid, citric acid, and potassium bitartrate non-hormonal prescription vaginal pH modulator (VPM) gel for the prevention of pregnancy. Expert Rev Clin Pharmacol. 2022;15(6):659–670. doi:10.1080/17512433.2022.2100347
   PubMed Web of Science ®Google Scholar
• Seeking Alpha. Evofem’s Phexxi fails in Phase 3 trial to prevent chlamydia, gonorrhea in women; 2022. Available from: https://archive.vn/M2K3r. Accessed December 19, 2022.
   Google Scholar
• Styczynski AR, Anwar KN, Sultana H, et al. In vitro antiretroviral activity and in vivo toxicity of the potential topical microbicide copper phthalocyanine sulfate. Virol J. 2015;12:132. doi:10.1186/s12985-015-0358-5
   PubMed Web of Science ®Google Scholar
• Hannaford PC, Ti A, Chipato T, Curtis KM. Copper intrauterine device use and HIV acquisition in women: a systematic review. BMJ Sex Reprod Health. 2020;46(1):17–25. doi:10.1136/bmjsrh-2019-200512
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Copper Intravaginal Contraception. RePORTER. Available from: https://reporter.nih.gov/project-details/10018526. Accessed February 19, 2023.
   Google Scholar
• Haraguchi Y, Sakurai H, Hussain S, Anner BM, Hoshino H. Inhibition of HIV-1 infection by zinc group metal compounds. Antiviral Res. 1999;43(2):123–133. doi:10.1016/s0166-3542(99)00040-6
   PubMed Web of Science ®Google Scholar
• Kenney J, Rodríguez A, Kizima L, et al. A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo. Antimicrob Agents Chemother. 2013;57(8):4001–4009. doi:10.1128/AAC.00796-13
   PubMed Web of Science ®Google Scholar
• Friedland BA, Hoesley CJ, Plagianos M, et al. First-in-human trial of miv-150 and zinc acetate coformulated in a carrageenan gel: safety, pharmacokinetics, acceptability, adherence, and pharmacodynamics. J Acquir Immune Defic Syndr. 2016;73(5):489–496. doi:10.1097/QAI.0000000000001136
   PubMed Web of Science ®Google Scholar
• Yarbrough VL, Winkle S, Herbst-Kralovetz MM. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum Reprod Update. 2015;21(3):353–377. doi:10.1093/humupd/dmu065
   PubMed Web of Science ®Google Scholar
• Levinson P, Choi RY, Cole AL, et al. HIV-Neutralizing Activity of Cationic Polypeptides in Cervicovaginal Secretions of Women in HIV-Serodiscordant Relationships. PLoS One. 2012;7(2):e31996. doi:10.1371/journal.pone.0031996
   PubMed Web of Science ®Google Scholar
• Tanphaichitr N, Srakaew N, Alonzi R, et al. Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides. Pharm Basel Switz. 2016;9(1):13. doi:10.3390/ph9010013
   Google Scholar
• Broliden K. Innate molecular and anatomic mucosal barriers against HIV infection in the genital tract of HIV‐exposed seronegative individuals. J Infect Dis. 2010;202(Suppl 3):S351–355. doi:10.1086/655964
   PubMedGoogle Scholar
• Srakaew N, Young CD, Sae-wu A, et al. Antimicrobial host defence peptide, LL-37, as a potential vaginal contraceptive. Hum Reprod. 2014;29(4):683–696. doi:10.1093/humrep/deu018
   PubMed Web of Science ®Google Scholar
• Lee SG, Kiattiburut W, Khongkha T, et al. 17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and microbicide against Neisseria gonorrhoeae. Hum Reprod. 2022;37(11):2503–2517. doi:10.1093/humrep/deac188
   PubMed Web of Science ®Google Scholar
• Perez-Caballero D, Zang T, Ebrahimi A, et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell. 2009;139(3):499–511. doi:10.1016/j.cell.2009.08.039
   PubMed Web of Science ®Google Scholar
• Bhardwaj G, Mulligan VK, Bahl CD, et al. Accurate de novo design of hyperstable constrained peptides. Nature. 2016;538(7625):329–335. doi:10.1038/nature19791
   PubMed Web of Science ®Google Scholar
• Hifnawy MS, Aboseada MA, Hassan HM, Tohamy AF, El Naggar EMB, Abdelmohsen UR. Nature-inspired male contraceptive and spermicidal products. Phytochem Rev. 2021;20(4):797–843. doi:10.1007/s11101-020-09721-5
   Web of Science ®Google Scholar
• Naz RK, Lough ML. Curcumin as a potential non-steroidal contraceptive with spermicidal and microbicidal properties. Eur J Obstet Gynecol Reprod Biol. 2014;176:142–148. doi:10.1016/j.ejogrb.2014.01.024
   PubMed Web of Science ®Google Scholar
• Baldeon-Vaca G, Marathe JG, Politch JA, et al. Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women. EBioMedicine. 2021;69:103478. doi:10.1016/j.ebiom.2021.103478
   PubMed Web of Science ®Google Scholar
• Kyurkchiev SD, Shigeta M, Koyama K, Isojima S. A human-mouse hybridoma producing monoclonal antibody against human sperm coating antigen. Immunology. 1986;57(3):489–492.
   PubMed Web of Science ®Google Scholar
• ZabBio Inc. An Exploratory Phase 1 Mechanism-of-Action Study of ZB-06, a Vaginal Film Containing HC4-N, an Anti-Sperm Monoclonal Antibody. clinicaltrials.gov; 2022. Available from: https://clinicaltrials.gov/ct2/show/NCT04731818. Accessed December 18, 2022.
   Google Scholar
• Anderson DJ, Politch JA, Cone RA, et al. Engineering monoclonal antibody-based contraception and multipurpose prevention technologies†. Biol Reprod. 2020;103(2):275–285. doi:10.1093/biolre/ioaa096
   PubMed Web of Science ®Google Scholar
• Riddler SA, Balkus JE, Parikh UM, et al. Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring. Clin Infect Dis off Publ Infect Dis Soc Am. 2019;69(3):523–529. doi:10.1093/cid/ciy909
   PubMed Web of Science ®Google Scholar
• Obiero J, Mwethera PG, Hussey GD, Wiysonge CS. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis. BMC Infect Dis. 2012;12(1):289. doi:10.1186/1471-2334-12-289
   PubMed Web of Science ®Google Scholar
• Thoueille P, Choong E, Cavassini M, Buclin T, Decosterd LA. Long-acting antiretrovirals: a new era for the management and prevention of HIV infection. J Antimicrob Chemother. 2022;77(2):290–302. doi:10.1093/jac/dkab324
   PubMed Web of Science ®Google Scholar
• Brown ER, Hendrix CW, van der Straten A, et al. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial. J Int AIDS Soc. 2020;23(11):e25634. doi:10.1002/jia2.25634
   PubMed Web of Science ®Google Scholar
• Derby N, Lal M, Aravantinou M, et al. Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo. Nat Commun. 2018;9(1):3881. doi:10.1038/s41467-018-06349-0
   PubMedGoogle Scholar
• Le AQ, Taylor J, Dong W, et al. Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction. Sci Rep. 2015;5(1):17607. doi:10.1038/srep17607
   PubMedGoogle Scholar